Skip to content
Science in Translation
Science in Translation

Cutting edge research meets innovation.

Our research concept is unique – we distinguish ourselves through our state-of-the-art methods and platforms.

Target Discovery and Validation

A critical first step in the development of therapies is the identification of actionable disease-specific targets or mechanistic pathways. Here at TRON, our state-of-the-art-equipped functional units work seamlessly through identification, validation, functional studies and target profiling. Throughout the process we keep the patient and clinical success top of mind.

Personalized Therapy Development

Patient-centered molecular analysis of a disease is a key pillar to personalized therapies and is at the heart of our translational research. Advances in genomic and proteomic screening technologies have greatly improved the capacity to detect relevant molecular alterations and have paved the way for personalized treatments.

Preclinical Vaccine Development

Following target validation and profiling, lead candidates are developed on a variety of delivery platforms, prioritizing the safety of any potential new product. Testing our findings in a variety of preclinical models allows us to evaluate immunogenicity and stability, empowering effective immunotherapies.

Cellular Therapy Development

Cellular immunotherapy is a rapid development and is transforming the way we treat diseases. In vitro-engineered immune cells have shown promising results in patients. We improve the efficacy of cellular therapies and we envision engineering cellular immunotherapies directly in the patient’s body.